[DXCM] DexCom, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 62.51 Change: 0.41 (0.66%)
Ext. hours: Change: 0 (0%)

chart DXCM

Refresh chart

Strongest Trends Summary For DXCM

DXCM is in the medium-term up 32% in 5 months. In the long-term up 130% in 2 years and up 445% above S&P in 18 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company?s ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that e

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 23.81% Sales Growth - Q/Q-13.64% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-12.04% ROE-15.34% ROI-14.97%
Current Ratio3.95 Quick Ratio3.45 Long Term Debt/Equity0.02 Debt Ratio0.25
Gross Margin67.74% Operating Margin-7.69% Net Profit Margin-8% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.9 M Cash From Investing Activities-25.9 M Cash From Operating Activities3.4 M Gross Profit46.5 M
Net Profit-12.9 M Operating Profit-12.7 M Total Assets189.3 M Total Current Assets146.2 M
Total Current Liabilities37 M Total Debt4.1 M Total Liabilities40.7 M Total Revenue72.8 M
Technical Data
High 52 week156.87 Low 52 week97.52 Last close155.44 Last change0.8%
RSI50.41 Average true range6.12 Beta1.28 Volume568.76 K
Simple moving average 20 days2.74% Simple moving average 50 days6.4% Simple moving average 200 days15.96%
Performance Data
Performance Week7.79% Performance Month1.93% Performance Quart30.85% Performance Half6.81%
Performance Year25% Performance Year-to-date29.75% Volatility daily2.35% Volatility weekly5.26%
Volatility monthly10.78% Volatility yearly37.35% Relative Volume615.21% Average Volume1.07 M
New High New Low

News

2019-09-17 16:05:00 | Dexcom Promotes Quentin Blackford to Chief Operating Officer

2019-09-17 08:30:00 | Dexcom Appoints Bridgette Heller to Board of Directors

2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing

2019-09-12 23:15:03 | Dexcom Inc DXCM EVP CFO Quentin S. Blackford Sold $1.5 million of Shares

2019-09-11 23:15:01 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $2.1 million of Shares

2019-09-09 11:05:00 | Dexcom G6® CGM System Now Available In Canada

2019-09-06 09:25:15 | Is DexCom, Inc. NASDAQ:DXCM Expensive For A Reason? A Look At Its Intrinsic Value

2019-09-05 19:15:04 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $1.7 million of Shares

2019-09-03 14:18:49 | 5 Internet of Things Stocks to Buy Now

2019-09-03 08:50:12 | Here's Why You Should Hold on to DexCom DXCM Stock Now

2019-08-31 07:29:00 | Is Dexcom a Buy?

2019-08-29 08:03:12 | DexCom DXCM Scales 52-Week High: What's Driving the Stock?

2019-08-27 16:22:22 | The 52-Week Highs You Never Heard About

2019-08-23 16:25:00 | Court Rules that the Patents Asserted against Dexcom CGM Systems are Invalid

2019-08-20 06:00:00 | Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs

2019-08-19 21:15:32 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $1.6 million of Shares

2019-08-15 17:09:13 | Edited Transcript of DXCM earnings conference call or presentation 27-Feb-18 9:30pm GMT

2019-08-06 15:09:00 | Why Insulet's Shares Are Rocketing 20.8% Higher Today

2019-08-03 16:05:00 | 5 Top Medical Device Stocks to Buy Now

2019-08-02 09:27:01 | DexCom DXCM Q2 Earnings and Revenues Surpass Estimates

2019-08-02 09:15:01 | DexCom DXCM Hits 52-Week High, Can the Run Continue?

2019-08-02 08:30:00 | Dexcom Announces Upcoming Conference Presentations

2019-08-01 15:37:09 | Edited Transcript of DXCM earnings conference call or presentation 31-Jul-19 8:30pm GMT

2019-08-01 09:29:50 | Does DexCom, Inc.'s NASDAQ:DXCM CEO Pay Matter?

2019-08-01 06:00:00 | What You'll Want to Know About DexCom's Q2 Earnings Results

2019-08-01 03:23:51 | DexCom DXCM Q2 2019 Earnings Call Transcript

2019-07-31 22:23:33 | Dow Jones Futures: Three Stock Market Lessons From Wednesday's Sell-Off; 5 Stocks Moving On Earnings

2019-07-31 17:19:10 | This Medtech Just Posted A Surprise Quarterly Gain — So Why Did It Dive?

2019-07-31 16:03:00 | Dexcom Reports Second Quarter 2019 Financial Results

2019-07-31 07:06:00 | The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster

2019-07-30 09:40:01 | Medical Products' Earnings Roster for Jul 31: MCK, HOLX & More

2019-07-25 07:37:11 | What's in the Offing for DexCom's DXCM Earnings in Q2?

2019-07-24 10:32:02 | DexCom DXCM May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-07-16 06:00:00 | FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars

2019-07-15 10:00:00 | 3 Top Diabetes Stocks to Watch in July

2019-07-12 13:06:05 | 3 Internet of Things Stocks to Buy for July

2019-07-11 09:00:01 | All You Need to Know About DexCom DXCM Rating Upgrade to Strong Buy

2019-07-09 20:15:02 | Dexcom Inc DXCM President, CEO and Chairman Kevin R Sayer Sold $877,500 of Shares

2019-07-09 12:22:04 | Profit from Surprise in Q2 2019 Earnings Season

2019-07-05 09:25:01 | Will MedTech Ease Investors' Concern & Outperform? 4 Picks

2019-07-03 08:00:12 | ETF & Stock Winners of Longest US Economic Expansion

2019-07-02 09:00:00 | Dexcom Schedules Second Quarter 2019 Earnings Release and Conference Call for July 31, 2019 at 4:30 p.m. Eastern Time

2019-06-26 12:57:38 | Need To Know: DexCom, Inc. NASDAQ:DXCM Insiders Have Been Selling Shares

2019-06-20 16:31:15 | IBD Stock Of The Day: Dexcom Nears Breakout On Medical Device Heyday

2019-06-17 17:52:02 | Here’s What Hedge Funds Think About DexCom, Inc. DXCM

2019-06-17 10:36:02 | Altair Engineering, Netgear, Fitbit, Microsoft and DexCom highlighted as Zacks Bull and Bear of the Day

2019-06-17 10:22:02 | The Zacks Analyst Blog Highlights: JinkoSolar, Salem Media, Ciena, DexCom and Zumiez

2019-06-14 13:27:05 | 3 "Internet of Things" Stocks to Buy Right Now

2019-06-14 08:43:12 | 5 Top-Ranked Stocks Crushing the Market in June

2019-06-14 08:09:00 | Dexcom Looks Like It Can Finally Break Out on the Topside